RenovoRx annual gross margin
2024
2025
RenovoRx Gross Margin Growth & History (RNXT)
RenovoRx's gross margin was 70.88% for fiscal 2025.
View full RenovoRx company overviewRenovoRx annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 70.88% | −29.12 pp |
| 2024 | 2024-12-31 | 100.00% | — |
RenovoRx quarterly gross margin
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 84.27% | +20.29 pp |
| Q1 2026 | 2026-03-31 | 85.08% | +32.80 pp |
| Q4 2025 | 2025-12-31 | 88.24% | — |
| Q3 2025 | 2025-09-30 | 80.08% | — |
| Q2 2025 | 2025-06-30 | 63.98% | — |
| Q1 2025 | 2025-03-31 | 52.28% | — |
RenovoRx gross margin trends
Across the available reported history, RenovoRx's gross margin decreased from 100.00% to 70.88%, a change of −29.12 percentage points. The latest reported quarter, Q2 2026, shows 84.27%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RenovoRx filings at SEC.gov ↗